Clinical trial
A Prospective, Multicenter, Randomized Controlled Clinical Trial to Evaluate the Efficacy and Safety of Transcatheter Tricuspid Valve Clipping Systems in Patients With Severe or Greater Tricuspid Regurgitation.
NCT07433504 is registered in ClinicalTrials.gov with Shanghai Huihe Medical Technology Co., Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Multicenter, Randomized Controlled Clinical Trial to Evaluate the Efficacy and Safety of Transcatheter Tricuspid Valve Clipping Systems in Patients With Severe or Greater Tricuspid Regurgitation.
- Lead sponsor
- Shanghai Huihe Medical Technology Co., Ltd
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- January 28, 2026
- Completion date
- December 31, 2031
- Enrollment
- 132 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
severe or greater tricuspid regurgitation